Getinge Announces Medical Device Recall

Getinge has announced a global medical device recall related to specific Sevoflurane vaporizers for Flow Family Anesthesia systems. To date, no patient or operator adverse events have been reported. Getinge has reported to relevant authorities according to applicable...

Research: Medical Instrument Processing Personnel May Be Exposed to Tissue, Blood and Patient Fluids Despite PPE

“This pilot documented substantial splashing and droplet dispersal during manual cleaning of medical instruments, and personnel got wet even though they were wearing all the recommended PPE,”

New Scrubs Made of Bacteria-Killing Textile

Livinguard, a Swiss-based leader in self-disinfecting hygiene technology, has launched an apparel line of permanent self-disinfecting scrubs, underscrubs and lab coats utilizing its EPA-registered bacteria-killing textile. Livinguard scrubs, that continuously...

Finnish Startup Surgify Shares New Bone Cutting Technology

Finnish startup Surgify – that recently launched an all-new and innovative surgical technology that allows surgeons to perform surgical operations on bones faster and safer – has seen its first use cases on patients, according to a news release. The first surgeries...

New Preoperative Surgical Planning Product for Total Hip Arthroplasty

Intellijoint Surgical has announced a new preoperative surgical planning product for total hip arthroplasty. Intellijoint VIEW is a surgical planning software that provides targets for functional cup position accounting for hip-spine relationship and implant templating to generate targets for leg length inequality and offset restoration without requiring CT imaging. VIEW integrates seamlessly to the Intellijoint HIP navigation system allowing surgeons to access and deliver their plans intraoperatively.

Intellijoint VIEW can be used by clinicians to assess a patient’s spinopelvic mobility with a new feature called the Target Zone Visualizer (TZV) to provide a functional acetabular cup target that is unique to each patient. The feature analyzes X-ray images of a patient in both sitting and standing positions and then applies the novel hip-spine relationship concepts to produce a cup target. VIEW can assist surgeons at identifying at-risk patients from adverse spinopelvic mobility conditions such as “stuck-standing” or “stuck-sitting” postures and with the TZV feature, help plan a patient-specific cup position to accommodate their mobility to help reduce the chance of impingement or dislocation. VIEW also enables implant templating, identifying leg length inequality and offset restoration needs for optimal implant sizing and selection.

Intellijoint Product Manager Lee Preiss states “We know that over 50% of total hip revisions are avoidable, and with VIEW we can offer surgeons additional value to do both pre-operative implant templating and patient-specific acetabular component position planning, addressing the major contributing factor to these revisions. Now surgeons can enter the OR with a clear and clinically relevant plan that can be delivered confidently with navigation.”

With targeted component positioning, the expectation is a drop in dislocations resulting in revisions. Intellijoint VIEW aids in discovering mobility specific orientation and planning for patient specific needs that can be integrated and delivered during surgery with Intellijoint HIP.

“The addition of Intellijoint VIEW to our suite of products, empowers surgeons with an easy-to-use software tool to prepare a unique plan for every patient. The creation of Intellijoint VIEW is in direct response to surgeon demand for a simple, web-based, open platform pre-operative planning tool that can integrate seamlessly with Intellijoint HIP for delivery in the OR. Intellijoint’s growing suite of products across the episode of care offers accessible cutting-edge technology to surgeons in both hospital and ambulatory surgery center settings,” said Intelljoint co-founder and CEO Armen Bakirtzian. “With accurate planning and measurements that can accommodate each individual patient, we expect consistent results that benefit patient outcomes and experience.”

For more information, visit



Submit a Comment

Your email address will not be published. Required fields are marked *